No Pharma Money
David Mitchell embraced by President Biden at the White House
News & Reports

The latest from P4ADNow

The latest news, research, policy analysis, and updates from the fight to lower prescription drug prices.

Stay Up To Date

News and reports from P4ADNow

Press Releases Feb 28, 2024

RELEASE: Inflation Reduction Act Balances The Rare Disease Innovation We Need With Prices We Can Better Afford, Patient With Rare Incurable Cancer Writes In Statement To Congress

David Mitchell, founder of Patients For Affordable Drug Now and a patient with a rare incurable cancer, urged Congress not to bend to drug industry scare tactics and fear-mongering and not to weaken…

Read Article
Press Releases Feb 28, 2024

Statement From P4AD Founder David Mitchell On Legislative Proposals To Support Patients With Rare Diseases

I want to thank you for holding this hearing “to discuss solutions to support patients living with rare diseases.”

Read Article
News Feb 23, 2024

The Week in Review in Prescription Drug Pricing

It’s been 18 months since the passage of the Inflation Reduction Act and we’re still buzzing about the drug price reforms that are helping millions of patients see cost savings.

Read Article
News Feb 16, 2024

The Week in Review in Prescription Drug Pricing

Marking an important step in protecting Medicare’s ability to negotiate lower prices for millions of patients, a Texas federal judge dismissed the lawsuit from trade association Pharmaceutical…

Read Article
Press Releases Feb 13, 2024

RELEASE: P4ADNow Launches TV Ads Exposing Congressman Don Davis’ Betrayal of Patients On Drug Pricing Promises

Washington, D.C. – Patients For Affordable Drugs Now (P4ADNow) today began running a series of TV ads to inform constituents in Congressman Don Davis’ district (D-NC1) that he has reneged on his…

Read Article
News Feb 9, 2024

The Week in Review in Prescription Drug Pricing

Senators Peter Welch and Amy Klobuchar were joined by patient advocates and health care experts for a panel discussion on Big Pharma’s use of patent thickets to extend market exclusivity and the new…

Read Article
News Feb 2, 2024

The Week in Review in Prescription Drug Pricing

As part of the sweeping reforms to lower prescription drug costs for millions of patients, the Centers For Medicare and Medicaid Services (CMS) sent initial price offers to drug manufacturers for the…

Read Article
Press Releases Feb 1, 2024

STATEMENT: Patients For Affordable Drugs Now Celebrates Historic Step Towards Lowering Drug Costs

Patients For Affordable Drugs Now, applauds the Centers for Medicare & Medicaid Services (CMS) as it takes the huge next step towards negotiating fair prices for essential medications.

Read Article
News Jan 26, 2024

The Week in Review in Prescription Drug Pricing

On Wednesday, January 31st, oral arguments will be heard in AstraZeneca’s legal challenge against Medicare’s ability to negotiate the price of the company’s diabetes and heart failure drug, Farxiga.

Read Article
News Jan 20, 2024

The Week in Review in Prescription Drug Pricing

In the health care policy arena, the focus centers around the passage of the Lower Costs, More Transparency Act (HR 5378).

Read Article
Explainers

Drug Pricing Explained

Videos breaking down the policies, practices, and decisions that shape what Americans pay for prescription drugs.

Watch The ETHIC Act Explained: What It Means for Patients on YouTube Patient advocate featured in The ETHIC Act Explained

The ETHIC Act Explained: What It Means for Patients

1:49 · Watch on YouTube

Watch How Big Pharma Games the Patent System on YouTube Merith Basey explains how Big Pharma games the patent system

How Big Pharma Games the Patent System

3:50 · Watch on YouTube

Watch Congress Delays Negotiation. Patients Pay the Price. on YouTube Dr. Ramachandran discusses delays to Medicare drug price negotiation

Congress Delays Negotiation. Patients Pay the Price.

0:51 · Watch on YouTube

Help us spread the word

Subscribe To Our YouTube
For Press

Patients are available for interviews

Looking for a patient perspective or expert comment? We can connect you with patients, policy experts, and the latest research on prescription drug pricing.

[email protected]

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.